Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity

References

• Akudugu JM, Neti PVSV, Howell RW. 2011. Changes in lognormal shape parameter guide design of patient-specific radiochemotherapy cocktails. Journal of Nuclear Medicine 52:642–649.
   PubMed Web of Science ®Google Scholar
• Azure MT, Archer RD, Sastry KSR, Rao DV, Howell RW. 1994. Biologic effect of 212Pb localized in the nucleus of mammalian cells: Role of recoil energy in the radiotoxicity of internal alpha emitters. Radiation Research 140:276–283.
   PubMed Web of Science ®Google Scholar
• Bishayee A, Hill HZ, Stein D, Rao DV, Howell RW. 2001. Free-radical initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiation Research 155:335–344.
   PubMed Web of Science ®Google Scholar
• Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, Erdi AK, Aydogan B, Costes S, Watson EE. 1999. MIRD Pamphlet No. 17: The dosimetry of nonuniform activity distributions – radionuclide S values at the voxel level. Journal of Nuclear Medicine 40:11S–36S.
   PubMed Web of Science ®Google Scholar
• Bouchet LG, Bolch WE, Weber DA, Atkins HL, Poston JW Sr. 1999. MIRD Pamphlet No. 15: Radionuclide S values in a revised model of the adult head and brain. Journal of Nuclear Medicine 40:62S–101S.
   Google Scholar
• Bouchet LG, Bolch WE, Blanco HP, Wessels BW, Siegel JA, Rajon DA, Clairand I, Sgouros G. 2003. MIRD Pamphlet No 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. Journal of Nuclear Medicine 44:1113–1147.
   PubMed Web of Science ®Google Scholar
• Brooks AL, Benjamin SA, Hahn FF, Brownstein DG, Griffith WC, McClellan RO. 1983. The induction of liver tumors by 239Pu citrate or 239PuO2 particles in the Chinese hamster. Radiation Research 96:135–151.
   PubMed Web of Science ®Google Scholar
• Brownell GL, Ellet WH, Reddy AR. 1968. Absorbed fractions for photon dosimetry. MIRD Pamphlet No. 3. Journal of Nuclear Medicine 9(suppl. 1):27–39.
   Google Scholar
• Cai Z, Pignol JP, Chan C, Reilly RM. 2010. Cellular dosimetry of 111In using Monte Carlo N-particle computer code: Comparison with analytic methods and correlation with in vitro cytotoxicity. Journal of Nuclear Medicine 51:462–470.
   PubMed Web of Science ®Google Scholar
• Charlton DE. 2000. Radiation effects in spheroids of cells exposed to alpha emitters. International Journal of Radiation Biology 76:1555–1564.
   PubMed Web of Science ®Google Scholar
• Conway JH, Sloane NJA. 1999. Sphere packings, lattices, and groups. 3rd ed. New York: Springer. 703 p.
   Google Scholar
• de Carlan L, Aubineau-Laniece I, Lemosquet A, Borissov N, Jourdain JR, Jeanbourquin D, Le Guen B, Franck D. 2003. Application of new imaging and calculation techniques to activity and dose assessment in the case of a 106Ru contaminated wound. Radiation Protection Dosimetry 105:219–223.
   PubMedGoogle Scholar
• Ellett WH, Callahan AB, Brownell GL. 1964. Gamma-ray dosimetry of internal emitters. I. Monte Carlo calculations of absorbed dose from point sources. British Journal of Radiology 37:45–52.
   PubMedGoogle Scholar
• Ellett WH, Callahan AB, Brownell GL. 1965. Gamma-ray dosimetry of internal emitters. II. Monte Carlo calculations of absorbed dose from uniform sources. British Journal of Radiology 38:541–544.
   Google Scholar
• Feinendegen LE, Bond VP, Booz J. 1994. The quantification of physical events within tissue at low levels of exposure to ionizing radiation. ICRU News (December): 9–12.
   Google Scholar
• Goddu SM, Rao DV, Howell RW. 1994. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. Journal of Nuclear Medicine 35:521–530.
   PubMed Web of Science ®Google Scholar
• Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S values: Self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Reston, VA: Society of Nuclear Medicine. 183 p.
   Google Scholar
• Guy MJ, Flux GD, Papavasileiou P, Flower MA, Ott RJ. 2003. RMDP: A dedicated package for 131I SPECT quantification, registration and patient-specific dosimetry. Cancer Biotherapy and Radiopharmaceuticals 18:61–69.
   PubMedGoogle Scholar
• Howell RW, Bishayee A. 2002. Bystander effects caused by nonuniform distributions of DNA-incorporated 125I. Micron 33:127–132.
   PubMed Web of Science ®Google Scholar
• Howell RW, Neti PV. 2005. Modeling multicellular response to nonuniform distributions of radioactivity: Differences in cellular response to self-dose and cross-dose. Radiation Research 163:216–221.
   PubMed Web of Science ®Google Scholar
• Howell RW, Goddu SM, Rao DV. 1994. Application of the linear-quadratic model to radioimmunotherapy: Further support for the advantage of longer-lived radionuclides. Journal of Nuclear Medicine 35:1861–1869.
   PubMed Web of Science ®Google Scholar
• Howell RW, Narra VR, Rao DV, Sastry KSR. 1990. Radiobiological effects of intracellular polonium-210 alpha emissions: A comparison with Auger-emitters. Radiation Protection Dosimetry 31:325–328.
   Web of Science ®Google Scholar
• Howell RW, Neti PV, Pinto M, Gerashchenko BI, Narra VR, Azzam EI. 2006. Challenges and progress in predicting biological responses to incorporated radioactivity. Radiation Protection Dosimetry 122: 521–527.
   PubMed Web of Science ®Google Scholar
• Humm JL, Cobb LM. 1990. Nonuniformity of tumor dose in radioimmunotherapy. Journal of Nuclear Medicine 31:75–83.
   PubMed Web of Science ®Google Scholar
• Humm JL, Macklis RM, Bump K, Cobb LM, Chin LM. 1993. Internal dosimetry using data derived from autoradiographs. Journal of Nuclear Medicine 34:1811–1817.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurements (ICRU). 1989. Tissue substitutes in radiation dosimetry and measurement. Bethesda, MD: ICRU. Report 44.
   Google Scholar
• International Commission on Radiation Units and Measurements (ICRU). 1993. Stopping powers and ranges for protons and alpha particles. Bethesda, MD: ICRU. Report 49.
   Google Scholar
• Jönsson B-A, Strand S-E, Larsson BS. 1992. A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues. Journal of Nuclear Medicine 33:1825–1832.
   PubMedGoogle Scholar
• Kalogianni E, Flux GD, Malaroda A. 2007. The use of BED and EUD concepts in heterogeneous radioactivity distributions on a multicellular scale for targeted radionuclide therapy. Cancer Biotherapy and Radiopharmceuticals 22:143–150.
   PubMedGoogle Scholar
• Kawrakow I. 2000. Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc, the new EGS4 version. Medical Physics 27:485–498.
   PubMed Web of Science ®Google Scholar
• Kvinnsland Y, Stokke T, Aurlien E. 2001. Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei. Radiation Research 155:288–296.
   PubMed Web of Science ®Google Scholar
• Ljungberg M, Frey E, Sjogreen K, Liu X, Dewaraja Y, Strand SE. 2003. 3D absorbed dose calculations based on SPECT: Evaluation for 111In/90Y therapy using Monte Carlo simulations. Cancer Biotherapy and Radiopharmaceuticals 18:99–107.
   PubMed Web of Science ®Google Scholar
• Loevinger R, Berman M. 1968. A schema for absorbed-dose calculations for biologically-distributed radionuclides. MIRD Pamphlet No. 1. Journal of Nuclear Medicine 9(Suppl. 1):7–14.
   PubMedGoogle Scholar
• Makrigiorgos GM, Adelstein SJ, Kassis AI. 1990a. Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium-99m-labeled microspheres and macroaggregates. Journal of the American Medical Association 264:592–595.
   PubMedGoogle Scholar
• Makrigiorgos GM, Ito S, Baranowska-Kortylewicz J, Vinter DW, Iqbal A, Van den Abbeele AD, Adelstein SJ, Kassis AI. 1990b. Inhomogeneous deposition of radiopharmaceuticals at the cellular level: Experimental evidence and dosimetric implications. Journal of Nuclear Medicine 31:1358–1363.
   PubMed Web of Science ®Google Scholar
• Malaroda A, Flux G, Ott R. 2005. The application of dose-rate volume histograms and survival fractions to multicellular dosimetry. Cancer Biotherapy and Radiopharmaceuticals 20:58–65.
   PubMed Web of Science ®Google Scholar
• Malaroda A, Flux GD, Buffa FM, Ott RJ. 2003. Multicellular dosimetry in voxel geometry for targeted radionuclide therapy. Cancer Biotherapy and Radiopharmaceuticals 18:451–461.
   PubMedGoogle Scholar
• McKay E. 2003. A software tool for specifying voxel models for dosimetry estimation. Cancer Biotherapy and Radiopharmaceuticals 18:379–392.
   PubMedGoogle Scholar
• National Council on Radiation Protection and Measurements (NCRP). 1979. Tritium and other radionuclide labelled organic compounds incorporated in genetic material. Bethesda, MD: NCRP. Report 63.
   Google Scholar
• Neti PV, Howell RW. 2003. When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry. Journal of Nuclear Medicine 44:2019–2026.
   PubMed Web of Science ®Google Scholar
• Neti PV, Howell RW. 2004. Isolating effects of microscopic nonuniform distributions of 131I on labeled and unlabeled cells. Journal of Nuclear Medicine 45:1050–1058.
   PubMed Web of Science ®Google Scholar
• Neti PV, Howell RW. 2006. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. Journal of Nuclear Medicine 47:1049–1058.
   PubMed Web of Science ®Google Scholar
• Neti PV, Howell RW. 2008. Lognormal distribution of cellular uptake of radioactivity: statistical analysis of alpha-particle track autoradiography. Journal of Nuclear Medicine 49:1009–1016.
   PubMed Web of Science ®Google Scholar
• Neti PVSV, Howell RW. 2007. Biological response to nonuniform distributions of 210Po in multicellular clusters. Radiation Research 168:332–340.
   PubMed Web of Science ®Google Scholar
• Nettleton JS, Lawson R. 1996. Cellular dosimetry of diagnostic radionuclides for spherical and ellipsoidal geometry. Physics in Medicine and Biology 41:1845–1854.
   PubMed Web of Science ®Google Scholar
• O'Donoghue JA. 1990. Isoeffect relationships for fractionated biologically targeted radiotherapy. Radiotherapy and Oncology 19:257–265.
   PubMedGoogle Scholar
• O'Donoghue JA, Wheldon TE. 1989. Dose-rate effects in biologically targeted radiotherapy. International Journal of Radiation Biology 56:745–749.
   PubMed Web of Science ®Google Scholar
• Oakberg EF. 1971. Spermatogonial stem-cell renewal in the mouse. The Anatomical Record 169:515–532.
   PubMedGoogle Scholar
• Pinto M, Howell RW. 2007. Concomitant quantification of targeted drug delivery and biological response in individual cells. Biotechniques 43(64):66–71.
   Google Scholar
• Pinto M, Azzam EI, Howell RW. 2006. Bystander responses in three-dimensional cultures containing radiolabeled and unlabeled human cells. Radiation Protection Dosimetry 122:252–255.
   PubMedGoogle Scholar
• Pinto M, Azzam EI, Howell RW. 2010. Investigation of adaptive responses in bystander cells in 3D cultures containing tritium-labeled and unlabeled normal human fibroblasts. Radiation Research 174:216–227.
   PubMed Web of Science ®Google Scholar
• Rajon D, Bolch WE, Howell RW. 2011. Lognormal distribution of cellular uptake of radioactivity: Monte-Carlo simulation of irradiation and cell killing in 3-dimensional populations in carbon scaffolds. Journal of Nuclear Medicine 52:926–933.
   PubMed Web of Science ®Google Scholar
• Rajon DA, Jokisch DW, Patton PW, Shah AP, Bolch WE. 2000. Voxel size effects in three-dimensional nuclear magnetic resonance microscopy performed for trabecular bone dosimetry. Medical Physics 27:2624–2635.
   PubMedGoogle Scholar
• Roeske JC, Aydogan B, Bardies M, Humm JL. 2008. Small-scale dosimetry: Challenges and future directions. Seminars in Nuclear Medicine 38:367–383.
   PubMedGoogle Scholar
• Sastry KSR, Haydock C, Basha AM, Rao DV. 1985. Electron dosimetry for radioimmunotherapy: Optimal electron energy. Radiation Protection Dosimetry 13:249–252.
   Google Scholar
• Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, Robbins RJ, Larson SM. 2004. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. Journal of Nuclear Medicine 45:1366–1372.
   PubMedGoogle Scholar
• Sgouros G, Roeske JC, McDevitt MR, Palm S, Allen BJ, Fisher DR, Brill AB, Song H, Howell RW, Akabani G, . 2010. MIRD Pamphlet No. 22 (abridged): Radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. Journal of Nuclear Medicine 51:311–328.
   PubMed Web of Science ®Google Scholar
• Snyder WS, Ford MR, Warner GG, Watson SB. 1975. ‘S’ absorbed dose per unit cumulated activity for selected radionuclides and organs. New York: Society of Nuclear Medicine.
   Google Scholar
• Spaic R, Ilic R, Dragovic M, Petrovic B. 2005. Generation of dose-volume histograms using Monte Carlo simulations on a multicellular model in radionuclide therapy. Cancer Biotherapy and Radiopharmaceuticals 20:320–324.
   PubMedGoogle Scholar
• Stabin MG. 2003. Developments in the internal dosimetry of radiopharmaceuticals. Radiation Protection Dosimetry 105:575–580.
   PubMed Web of Science ®Google Scholar
• Uusijarvi H, Bernhardt P, Forssell-Aronsson E. 2008. Tumour control probability (TCP) for non-uniform activity distribution in radionuclide therapy. Physics in Medicine and Biology 53: 4369–4381.
   PubMedGoogle Scholar
• Wessels BW, Griffith MH. 1986. Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models. Journal of Nuclear Medicine 27:1308–1314.
   PubMed Web of Science ®Google Scholar